[Against insulin resistance. Insulin sensitizers].
Verspohl
Eugen J
EJ
Institut für Pharmazeutische und Medizinische Chemie Hittorfstr. 58-62, 48149 Münster.
Weiland
Felix
F
D000818:Animals; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance / Q000502:physiology*; D000077205:Pioglitazone; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077205:Pioglitazone
Der Insulinresistenz entgegen. Insulinsensitizer.